Czechia, Jan. 8 -- Czechia based Boehringer Ingelheim, spol. s r.o. has secured contract from Fakultni nemocnice Plzen for Antineoplastic and immunomodulating agents - Antineoplastica and immunomodulators 2025-II. The value of the contract is worth 5074368134 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....